Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia

Experimental Gerontology

Volumn 39, Issue 3, 2004, Pages 443-450

  Ravaglia, G ^a   Forti, P ^a   Maioli, F ^a   Servadei, L ^a   Martelli, M ^a   Arnone, G ^a   Talerico, T ^a   Zoli, M ^a   Mariani, E ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Ageing; Atherosclerosis; Cardiovascular disease; Comorbidity; Dementia; Inflammation; Plasma total homocysteine; Serum C reactive protein

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

AGED; AGING; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; FEMALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIOECONOMICS;

EID: 1342265391     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2003.11.005     Document Type: Article

References (45)

1. Anderson J.L., Muhlestein J.B., Horne B.D., Carlquist J.F., Bair T.L., Madsen T.E., Pearson R.R. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 102:2000;1227-1232.
2. Becker A., Van Hinsbergh V.W., Kostense P.J., Jager A., Dekker J.M., Nijpels G., Heine R.J., Bouter L.M., Stehouwer C.D. Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule I, but not with C-reactive protein and type 2 diabetic and non-diabetic subjects - the hoorn study. Eur. J. Clin. Invest. 30:2000;763-770.
3. Bloemerkamp D.G., Mali W.P., Tanis B.C., Rosendaal F.R., Van der Bosch M.A., Kemmeren J.M., Algra A., Visseren F.L., Van der Graaf Y. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration. Eur. J. Clin. Invest. 32:2002;549-555.
4. Bravo G., Dubois M.F., Hébert R., De Wals P., Messier L. A prospective evaluation of the Charlson comorbidity index for use in long-term care patients. J. Am. Geriatr. Soc. 50:2002;740-745.
5. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Niklas B.J., Sutton-Tyrrel K., Tracy R.P., Rubin S.M., Harris T.B., Pahor M. Inflammatory markers and cardiovascular disease (The health, aging, and body composition [Health ABC] study). Am. J. Cardiol. 92:2003;522-528.
6. Cremonini F., Gasbarrini A., Armuzzi A., Gasbarrini G. Helicobacter pylori-related diseases. Eur. J. Clin. Invest. 31:2001;431-437.
7. Danesh J., Collins R., Appelby P., Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocite count with coronary heart disease: meta-analyses of prospective studies. JAMA. 279:1998;1477-1482.
8. Desai A., Lankford H.A., Warren J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation. 25:2001;179-186.
9. Friso S., Jacques P.F., Wilson P.W.F., Rosemberg I.H., Selhub J. Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 103:2001;2788-2791.
10. Folsom A.R., Desvarieux M., Nieto F.J., Boland L.L., Ballantyne C.M., Chambless L.E. B vitamin status and inflammatory markers. Atherosclerosis. 169:2003;139-174.
11. Fuchs D., Jaeger M., Widner B., Wirleitner B., Artner-Dworzak E., Leblhuber F. Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake? Clin. Chem. Lab. Med. 39:2001;691-694.
12. Herrmann W., Quast S., Ullrich M., Schultze H., Bodis M., Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis. 144:1999;91-100.
13. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran L.J. Jr., Kohl B., Rao V., Kisiel W., Stern D.M., Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107:2001;675-683.
14. Joosten E., Lesaffre E., Riezler R., Ghekiere V., Dereymaeker L., Pelemans W., Dejaejer E. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease ? J. Gerontol. Med. Sci. (52A):1997;M76-M79.
15. Kaptan K., Beyan C., Ural A.U., Cetin T., Avcu F., Gulsen M., Finci R., Yalcin A. Helicobacter pylori. Is it a novel causative agent in vitamin B12 deficiency? Arch. Intern. Med. 160:2000;1349-1353.
16. Leung W.K., Ma P.K., Choi P.C., Ching J.Y., Ng A.C., Poon P., Woo K.S., Sung J.J. Correlation between Helicobacter pylori infection, gastric inflammation and serum homocysteine concentration. Helicobacter. 6:2001;146-150.
17. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
18. Macy E.M., Hayes T.E., Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43:1997;52-58.
19. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ. 312:1996;1061-1065.
20. Mojiminiyi O.A., Abdella N., Moussa M.A., Akanij A.O., Al Mohammedi H., Zaki M. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diab. Res. Clin. Prac. 58:2002;37-44.
21. Nagga K., Rajani R., Mardh E., Borch K., Mardh S., Marcusson J. Cobalamin, folate, methylmalonic acid, and homocysteine and gastritis markers in dementia. Dement. Geriatr. Cogn. Disord. 16:2003;269-275.
22. Nilsson K., Hultberg B., Gustafson L. Lack of association between plasma homocysteine and inflammation in psychogeriatric patients. Dement. Geriatr. Cogn. Disord. 14:2002;151-155.
23. Nygard O., Refsum H., Ueland P.M., Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: the hordaland homocysteine study. Am. J. Clin. Nutr. 67:1998;263-270.
24. Parnetti L., Bottiglieri T., Lowenthal D. Role of homocysteine in age-related vascular and non-vascular diseases. Aging Clin. Exp. Res. 9:1997;241-257.
25. Pearson T.A. New tools for coronary risk assessment. Circulation. 105:2002;886-892.
26. Pilotto A. Helicobacter pylori associated peptic ulcer disease in older patients: current management strategies. Drugs Aging. 18:2001;487-494.
27. Pilotto A., Malfertheiner P. Review article: an approach to Helicobacter pylori infection in the elderly. Aliment. Pharmacol. Ther. 16:2002;683-691.
28. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 103:2001;2717-2723.
29. Ravaglia G., Forti P., Maioli F., Bastagli L., Facchini A., Mariani E., Savarino L., Sassi S., Cucinotta D., Lenaz G. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged ≥90 y. Am. J. Clin. Nutr. 71:2000;590-598.
30. Ravaglia G., Forti P., Maioli F., Orlanducci P., Sacchetti L., Flisi E., Dalmonte E., Martignani A., Cucinotta D., Cavalli G. Conselice study: a population based study of brain aging in a municipality of the Emilia Romagna Region: Conselice, A.U.S.L. Ravenna. Design and methods. Arch. Gerontol. Geriatr. 1:(suppl. 1):2001;313-324.
31. Ravaglia G., Forti P., Maioli F., Sacchetti L., Mariani E., Nativio V., Talerico T., Vettori C., Macini P.L. Education, occupation, and prevalence of dementia: findings from the Conselice study. Dement. Geriatr. Cogn. Disord. 14:2002;90-100.
32. Richie R.F., Whitley R.J. General clinical tests. Tietz N.W. Clinical Guide to Laboratory Tests. second ed :1990;166-167 WB Saunders, Philadelphia.
33. Ridker P.M., Cushman M., Stampfer M.J., Russell P.T., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:1997;973-979.
34. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342:2000;836-843.
35. Rohde L.E.P., Hennekens C., Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am. J. Cardiol. 84:1999;1018-1022.
36. Rothenbacher D., Hoffmeister A., Brenner H., Koenig W. Physical activity, coronary heart disease, and inflammation response. Arch. Intern. Med. 163:2003;1200-1205.
37. Schmidt R., Schmidt H., Curb J.D., Masaki K., White L.R., Launer L.J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann. Neurol. 52:2002;168-174.
38. Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosemberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698.
39. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346:2002;476-483.
40. Stangler O.H., Semmelrock H.J., Rehak P., Tiran B., Meinitzer A., Rigler B., Tiran A. Hyperhomocyst(e)inemia and Chalmydia pneumoniae IgG seropositivity in patients with coronary artery disease. Atherosclerosis. 162:2002;157-162.
41. Tariot P.N. Medical management of advanced dementia. J. Am. Geriatr. Soc. 51:2003;S305-S313.
42. Vasan R.S., Beiser A., D'Agostino R.B., Levy D., Selhub J., Jacques P.F., Rosenberg I.H., Wilson P.W. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. 289:2003;1251-1257.
43. Vermeulen E.G.J., Rauwerda J.A., van den Berg M., de Jong S.C., Schalkwijk C., Twisk J.W.R., Stehouwer C.D.A. Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. Eur. J. Clin. Invest. 33:2003;209-215.
44. Wald D.S., Law M., Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 325:2002;1202-1208.
45. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338:1998;1042-1050.